Frederick L. Hall
Amministratore Delegato presso GenVivo, Inc.
Profilo
Frederick L.
Hall co-founded Epeius Biotechnologies Corp.
in 2000 and currently serves as President, Chief Executive Officer, and Chief Scientific Officer.
Prior to co-founding Epeius Biotechnologies, he was Director of Research in the Departments of Orthopaedic Surgery, Cardiothoracic Surgery, and Colorectal Surgery, and Associate Professor of Molecular Pharmacology and Toxicology at the University of Southern California School of Pharmacy.
Dr. Hall received a Bachelor's degree in Biology from the University of Colorado and a PhD in Physiology and Biophysics from Colorado State University.
Posizioni attive di Frederick L. Hall
| Società | Posizione | Inizio |
|---|---|---|
GenVivo, Inc.
 GenVivo, Inc. BiotechnologyHealth Technology GenVivo, Inc. develops targeted delivery system that transports genes directly to diseased areas in the body. Its products are used for the treatment of metastatic cancer. The company was founded in 2000 by Erlinda Maria Gordon and Frederick L. Hall and is headquartered in San Marino, CA. | Amministratore Delegato | 01/01/2000 |
Formazione di Frederick L. Hall
| The University of Colorado | Undergraduate Degree |
| Colorado State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
GenVivo, Inc.
GenVivo, Inc. BiotechnologyHealth Technology GenVivo, Inc. develops targeted delivery system that transports genes directly to diseased areas in the body. Its products are used for the treatment of metastatic cancer. The company was founded in 2000 by Erlinda Maria Gordon and Frederick L. Hall and is headquartered in San Marino, CA. | Health Technology |
- Borsa valori
- Insiders
- Frederick L. Hall
